Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8700324 | Journal of Oral and Maxillofacial Surgery | 2018 | 24 Pages |
Abstract
A brief review of the relevant literature and a detailed evaluation of current cases led to the conclusion that denosumab therapy should be considered a therapeutic option for large central GCGs of the jaws. The results of this study suggest denosumab is a successful treatment option. A treatment length no shorter than 12Â months is recommended and monitoring of treatment response can be well managed by positron-emission tomographic computed tomography or magnetic resonance imaging.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Marius MBChB, BChD, MChD, Tamara MD, Sabine MD, Martin MD, DMD, Daniel Fritz MD, DMD, Claudio MD, DMD,